-
The Burden of Migraine in Brazil's Private Healthcare System: Results From the Brazil Migraine Real-World Evidence (BREM) Study
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns and Clinical Characteristics Among Patients With Crohn’s Disease Receiving First- and Second-Line Biologic Treatments in The United States
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and the Economic Burden of Neovascular Age-Related Macular Degeneration (nAMD): A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
An Evaluation of PhlexNeuron, an Internal, Proprietary Artificial Intelligence (AI) Tool for Systematic Literature Review (SLR) Screening
Mar 10, 2025, 14:00 PM -
The Importance of Medicare Advantage Plan Design and Impact on Health Equity
Mar 10, 2025, 14:00 PM -
Psychometric Evidence Supporting the Use of the EQ-5D in Long COVID: A Systematic Review
Mar 10, 2025, 14:00 PM -
Estimating Sample Size for Training Ensemble Machine Learning Models
Mar 10, 2025, 14:00 PM -
Economic Feasibility of 'Pay One Price': An Analysis of Three Biosimilar Molecules with Different Prices and Indicated for Rheumatoid Arthritis in a Medium Size HMO
Mar 10, 2025, 14:00 PM -
Navigating Uncertainty in Overall Survival Data: Insights from Positive Canadian HTAs on Lung Cancer Therapies
Mar 10, 2025, 14:00 PM -
Prescription Cost Dynamics in Chronic Disease Management: The Role of PMBJP-Scheme in Enhancing Affordability in India
Mar 10, 2025, 14:00 PM -
Application of Generative Artificial Intelligence for Extracting Structured Data from Unstructured Bladder Cancer Pathology Reports
Mar 10, 2025, 14:00 PM -
Impact of NGS Testing Timing on Real-World Treatment Patterns and Clinical Outcomes in Colorectal Cancer: A Retrospective Observational Study
Mar 10, 2025, 14:00 PM -
Impact of Primary Care Subsidies on Healthcare Utilization: Evidence From Singapore's Merdeka Generation Package
Mar 10, 2025, 14:00 PM -
Trend of Cervical Cancer Mortality in Colombia From 1998 to 2022
Mar 10, 2025, 14:00 PM -
The Emerging Potential of International Reference Pricing (IRP) in the US: An Analysis of Trends, Challenges, Opportunities and learnings from Europe
Mar 10, 2025, 14:00 PM -
Developing a Checklist for Patient Engagement in Rare Disease Value Research
Mar 10, 2025, 14:00 PM -
Target Aggregate Data Adjustment Method (TADA): A Solution for Performing Transportability Analysis with Only Aggregate-Level Data in the Target Population
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Continuous Glucose Monitoring with Predictive Alarms for Type 1 Diabetes in Chile (T1D): Perspective of the Explicit Health Guarantees Regime.
Mar 10, 2025, 14:00 PM -
Impact of Treatment Response on Quality of Life and Health-Related Utility Values in Hepatitis: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Evaluation of the Impact of Fezolinetant vs Placebo on Indirect Costs Among Women With VMS Associated With Menopause
Mar 10, 2025, 14:00 PM